Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients
- 31 March 2004
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 94 (1) , 111-117
- https://doi.org/10.1016/j.ijcard.2003.08.001
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Cerivastatin, a Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor, Improves Endothelial Function in Elderly Diabetic Patients Within 3 DaysCirculation, 2001
- Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeksJournal of the American College of Cardiology, 2001
- Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary HypercholesterolemiaCirculation, 2001
- An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In VitroCirculation, 2001
- Short-Term Atorvastatin Treatment Improves Endothelial Function in Hypercholesterolemic WomenJournal of Cardiovascular Pharmacology, 2000
- Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive ProteinCirculation, 1999
- Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)Circulation, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.Circulation, 1994